Cargando…
AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage
Intracerebral hemorrhage (ICH) refers to bleeding in the brain and is associated with the release of large amount of inflammasomes, and the activation of different cell death pathways. These cell death pathways lead to removal of inactivated and damaged cells and also result in neuronal cell damage....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206581/ https://www.ncbi.nlm.nih.gov/pubmed/30410928 http://dx.doi.org/10.1155/2018/3706047 |
_version_ | 1783366376540340224 |
---|---|
author | Lin, Xiao Ye, Haotuo Siaw-Debrah, Felix Pan, Sishi He, Zibin Ni, Haoqi Xu, Zhu Jin, Kunlin Zhuge, Qichuan Huang, Lijie |
author_facet | Lin, Xiao Ye, Haotuo Siaw-Debrah, Felix Pan, Sishi He, Zibin Ni, Haoqi Xu, Zhu Jin, Kunlin Zhuge, Qichuan Huang, Lijie |
author_sort | Lin, Xiao |
collection | PubMed |
description | Intracerebral hemorrhage (ICH) refers to bleeding in the brain and is associated with the release of large amount of inflammasomes, and the activation of different cell death pathways. These cell death pathways lead to removal of inactivated and damaged cells and also result in neuronal cell damage. Pyroptosis is a newly discovered cell death pathway that has gained attention in recent years. This pathway mainly depends on activation of caspase-1-mediated cascades to cause cell death. We tested a well-known selective inhibitor of caspase-1, AC-YVAD-CMK, which has previously been found to have neuroprotective effects in ICH mice model, to ascertain its effects on the activation of inflammasomes mediated pyroptosis. Our results showed that AC-YVAD-CMK could reduce caspase-1 activation and inhibit IL-1β production and maturation, but has no effect on NLRP3 expression, an upstream inflammatory complex. AC-YVAD-CMK administration also resulted in reduction in M1-type microglia polarization around the hematoma, while increasing the number of M2-type cells. Furthermore, AC-YVAD-CMK treated mice showed some recovery of neurological function after hemorrhage especially at the hyperacute and subacute stage resulting in some degree of limb movement. In conclusion, we are of the view that AC-YVAD-CMK could inhibit pyroptosis, decrease the secretion or activation of inflammatory factors, and affect the polarization of microglia resulting in improvement of neurological function after ICH. |
format | Online Article Text |
id | pubmed-6206581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-62065812018-11-08 AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage Lin, Xiao Ye, Haotuo Siaw-Debrah, Felix Pan, Sishi He, Zibin Ni, Haoqi Xu, Zhu Jin, Kunlin Zhuge, Qichuan Huang, Lijie Biomed Res Int Research Article Intracerebral hemorrhage (ICH) refers to bleeding in the brain and is associated with the release of large amount of inflammasomes, and the activation of different cell death pathways. These cell death pathways lead to removal of inactivated and damaged cells and also result in neuronal cell damage. Pyroptosis is a newly discovered cell death pathway that has gained attention in recent years. This pathway mainly depends on activation of caspase-1-mediated cascades to cause cell death. We tested a well-known selective inhibitor of caspase-1, AC-YVAD-CMK, which has previously been found to have neuroprotective effects in ICH mice model, to ascertain its effects on the activation of inflammasomes mediated pyroptosis. Our results showed that AC-YVAD-CMK could reduce caspase-1 activation and inhibit IL-1β production and maturation, but has no effect on NLRP3 expression, an upstream inflammatory complex. AC-YVAD-CMK administration also resulted in reduction in M1-type microglia polarization around the hematoma, while increasing the number of M2-type cells. Furthermore, AC-YVAD-CMK treated mice showed some recovery of neurological function after hemorrhage especially at the hyperacute and subacute stage resulting in some degree of limb movement. In conclusion, we are of the view that AC-YVAD-CMK could inhibit pyroptosis, decrease the secretion or activation of inflammatory factors, and affect the polarization of microglia resulting in improvement of neurological function after ICH. Hindawi 2018-10-16 /pmc/articles/PMC6206581/ /pubmed/30410928 http://dx.doi.org/10.1155/2018/3706047 Text en Copyright © 2018 Xiao Lin et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lin, Xiao Ye, Haotuo Siaw-Debrah, Felix Pan, Sishi He, Zibin Ni, Haoqi Xu, Zhu Jin, Kunlin Zhuge, Qichuan Huang, Lijie AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage |
title | AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage |
title_full | AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage |
title_fullStr | AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage |
title_full_unstemmed | AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage |
title_short | AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage |
title_sort | ac-yvad-cmk inhibits pyroptosis and improves functional outcome after intracerebral hemorrhage |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206581/ https://www.ncbi.nlm.nih.gov/pubmed/30410928 http://dx.doi.org/10.1155/2018/3706047 |
work_keys_str_mv | AT linxiao acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage AT yehaotuo acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage AT siawdebrahfelix acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage AT pansishi acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage AT hezibin acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage AT nihaoqi acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage AT xuzhu acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage AT jinkunlin acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage AT zhugeqichuan acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage AT huanglijie acyvadcmkinhibitspyroptosisandimprovesfunctionaloutcomeafterintracerebralhemorrhage |